エストロン-3-グルクロニド(E1G)測定キット DetectX Estrone-3-Glucuronide (E1G) ELISA Kit

• （i）生存可能な精子が生き残り、卵子に到達することを可能にするリスクが低い場合の初期段階
• （ii）受精の可能性が最大になる段階、 受精期
• （iii）卵子が生存不能である絶対的な不妊の時期。

参考文献

1. Adlercreutz, H., Lehtinen, T. and Kairento, A.-L. "Prediction of ovulation by urinary estrogen assays.", J. Steroid Biochem., 12, 395～401 (1980).
2. Stanczyk, F.Z., Miyakawa, I. and Goebelsmann, U., "Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.", Am. J. Obstet Gynecol, 137, 443～450 (1980).
3. Collins, W.P., Branch, C.M., Collins, P.O. and Sallam, H.N., "Biochemical indices of the fertile period in women.", Int. J. Fertil., 26, 196～202 (1981).
4. Brown, J.8. and Gronow, M., "Endocrinology of ovulation prediction. in Clinical Reproductive Endocrinology (R.P. Shearman, Editor).", Churchill Livingstone, Edinburgh,p.165～184 (1985).
5. Henderson, BE., Ross, RK., "Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer.", Cancer Res., 42, 3232～3239 (1982).
6. Key, TJ., "Hormones and cancer in humans.", Mutat Res.,, 333, 59～67 (1995).
7. Ursin G, et al., "Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and White women?", Cancer Res., 61, 3326～3329 (2001).
8. Lukanova, A., Kaaks, R., "Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.", Cancer Epidemiol. Biomarkers Prev., 14, 98～107 (2005).
9. Persson, I., "Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings.", J. Steroid Biochem. Mol. Biol., 74,357～364 (2000).